Talviraline
Alternative Names: Bay 10-8979; HBY 097Latest Information Update: 24 Oct 2021
At a glance
- Originator Aventis; Bayer
- Developer Bayer
- Class Antiretrovirals
- Mechanism of Action RNA-directed DNA polymerase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued HIV-1 infections